Form D · Biotechnology

One Health Group, Inc.

Cazenovia, NY · CIK 0001972911

Offering snapshot reported Dec 18, 2024 · SEC filing

Reported sold
Yet to sell
Offering amount: $5M
Investors reported
0
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 18, 2024InitialYet to sellNo comparison0SEC filing
May 24, 2024InitialYet to sellNo comparison0SEC filing
May 24, 2024Amendment$2,577,000$148,000vs Feb 26, 20248SEC filing
Feb 26, 2024Amendment$2,429,000No comparison8SEC filing
Aug 29, 2023Amendment$660,000No comparison8SEC filing
May 8, 2023InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity, Debt
Exemptions
04, 06c
Duration over one year
No
Business combination
No
Sales commissions
$175K (estimated)
Finders' fees
$0
Form D file number
021-532465

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Jerome E. Connolly1881584Ashton Stewart & Co., Inc. · CRD 112386

Source: Form D, filed Dec 18, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Albert Di Rienzo Director, Executive
Carl Eckstein Director
Michael Stanfield Director
Mark Wang Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3053 West Lake Road
Cazenovia, NY, 13035